Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Free Cash Flow: 2023-2025

Historic Free Cash Flow for Immunocore Holdings (IMCR) over the last 3 years, with Sep 2025 value amounting to -$5.2 million.

  • Immunocore Holdings' Free Cash Flow fell 125.64% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year decrease of 85.17%. This contributed to the annual value of $20.9 million for FY2024, which is 940.56% up from last year.
  • Latest data reveals that Immunocore Holdings reported Free Cash Flow of -$5.2 million as of Q3 2025, which was down 120.37% from $25.6 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Free Cash Flow registered a high of $25.6 million during Q2 2025, and its lowest value of -$18.6 million during Q4 2023.
  • For the 3-year period, Immunocore Holdings' Free Cash Flow averaged around $3.5 million, with its median value being $137,000 (2025).
  • Over the last 5 years, Immunocore Holdings' Free Cash Flow had its largest YoY gain of 1,814.15% in 2024, and its largest YoY loss of 166.56% in 2024.
  • Quarterly analysis of 3 years shows Immunocore Holdings' Free Cash Flow stood at -$18.6 million in 2023, then increased by 5.47% to -$17.5 million in 2024, then plummeted by 125.64% to -$5.2 million in 2025.
  • Its Free Cash Flow stands at -$5.2 million for Q3 2025, versus $25.6 million for Q2 2025 and $137,000 for Q1 2025.